CompletedNCT01114737
Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Phenylketonuria (PKU) Patients
Medication studyAges 8–65United States + CanadaADHD
Understand this study
Who was this study for?
Listed age limits: 8 years to 65 years.
- Listed locations
- La Jolla and 35 more locationsSee all locations and recruitment
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Study information
Study start dateAugust 2010
- Recruitment status
- Completed
- Enrollment listed in the registry
- 206
- Sponsor
- BioMarin Pharmaceutical
- Sponsor type
- Pharmaceutical company
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Locations
- United States, Canada
- Age range
- From 8 Years to 65 Years
- Official registry ID
- NCT01114737
- Official title
Show the full official title
A Double-blind, Placebo-controlled, Randomized Study to Evaluate the Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Subjects With Phenylketonuria
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
La Jolla, United States · Los Angeles, United States · Palo Alto, United States
33 more locations
- San Francisco, United States
- Aurora, United States
- Washington D.C., United States
- Gainesville, United States
- Tampa, United States
- Atlanta, United States
- Chicago, United States
- Indianapolis, United States
- Boston, United States
- Minneapolis, United States
- Albany, United States
- Buffalo, United States
- Rochester, United States
- Chapel Hill, United States
- Cleveland, United States
- Portland, United States
- Hershey, United States
- Philadelphia, United States
- Pittsburgh, United States
- Nashville, United States
- Dallas, United States
- Madison, United States
- Milwaukee, United States
- Calgary, Canada
- Edmonton, Canada
- Vancouver, Canada
- Winnipeg, Canada
- Halifax, Canada
- Hamilton, Canada
- Kingston, Canada
- London, Canada
- Toronto, Canada
- Montreal, Canada
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is BioMarin Pharmaceutical, a pharmaceutical company.
Did this study involve medication?
Yes. The study involved medication, including Sapropterin dihydrochloride and Placebo.
Who was this study for?
Listed age limits: 8 years to 65 years.
